Carbon + Oxygen Compounds (C + O)
Found 868,090 compounds containing Carbon + Oxygen. Page 233 of 17362.
C
Carbon
Basis of organic chemistry
O
Oxygen
Essential for respiration
| Formula | IUPAC Name | Common Name | Mol. Weight |
|---|---|---|---|
| C12H12I3NO4 | 2-[3-(butanoylamino)-2,4,6-triiodo-phenoxy]acetic acid | BRN 2706420 | 614.94 |
| C17H24FNO | 4-(4,4-dimethyl-1-piperidyl)-1-(4-fluorophenyl)butan-1-one | K4T36YKD6R | 277.38 |
| C18H27NOS | 4-(3-azaspiro[5.5]undecan-3-yl)-1-(2-thienyl)butan-1-one | BRN 1347957 | 305.50 |
| C18H26FNO | 3-[2-(4-fluorophenoxy)ethyl]-3-azaspiro[5.5]undecane | 1228-30-4 | 291.40 |
| C19H22ClNO | 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine;hydrochloride | 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride | 315.80 |
| C17H14N2O2 | 1-(2-methoxyphenyl)azonaphthalen-2-ol | Sudan Red G | 278.30 |
| C13H11N7O | 4,7-diamino-2-phenyl-pteridine-6-carboxamide | 6-Pteridinecarboxamide, 4,7-diamino-2-phenyl- | 281.27 |
| C15H12N4O2 | 4,6-diphenoxy-1,3,5-triazin-2-amine | 4,6-diphenoxy-1,3,5-triazin-2-amine | 280.28 |
| C19H28FNO | 3-[3-(4-fluorophenoxy)propyl]-3-azaspiro[5.5]undecane | 1231-67-0 | 305.40 |
| C20H28O2 | (3S,8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | ethynodiol | 300.40 |
| C18H24O4 | (16R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2,3,16,17-tetrol | (16R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2,3,16,17-tetrol | 304.40 |
| C21H18O | 1-(1,2-diphenylvinyl)-4-methoxy-benzene | 4-stilben-alpha-yl-anisole | 286.40 |
| C17H20N2O2S | 1,3-bis(4-ethoxyphenyl)isothiourea | 1,3-bis(4-ethoxyphenyl)isothiourea | 316.40 |
| C21H29NO3 | 2-(dimethylamino)ethanol;2-methyl-4-(4-phenylphenyl)butanoic acid | SCHEMBL125407 | 343.50 |
| C17H18O2 | 2-methyl-4-(4-phenylphenyl)butanoic acid | 4-(4-Biphenylyl)-2-methylbutanoic acid | 254.32 |
| C20H28FNO | 4-(2-azaspiro[4.6]undecan-2-yl)-1-(4-fluorophenyl)butan-1-one | BRN 1431874 | 317.40 |
| C21H30O2 | methyl (1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate | METHYL DEHYDROABIETATE | 314.50 |
| C20H26O3 | 17-ethynyl-10,17-dihydroxy-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | NCIOpen2_008089 | 314.40 |
| C21H23FO | 1-[1-cyclohexyl-2-(2-fluorophenyl)vinyl]-4-methoxy-benzene | 1-[1-cyclohexyl-2-(2-fluorophenyl)vinyl]-4-methoxy-benzene | 310.40 |
| C21H17FO | 1-fluoro-2-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 1-fluoro-2-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 304.40 |
| C21H17FO | 1-fluoro-4-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 1-fluoro-4-[2-(4-methoxyphenyl)-2-phenyl-vinyl]benzene | 304.40 |
| C18H20F2N2O | N,N-bis(2-fluoroethyl)-4-[(4-methoxyphenyl)iminomethyl]aniline | N-(p-(Bis(2-fluoroethyl)amino)benzylidene)-p-anisidine | 318.40 |
| C20H26O4 | 17-ethynyl-10-hydroperoxy-17-hydroxy-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | NCIOpen2_009978 | 330.40 |
| C21H26N2O | 3-methyl-2-(2-morpholinoethyl)-2-(1-naphthyl)butanenitrile | 1238-65-9 | 322.40 |
| C20H28FNO2 | 4-(7,9-dimethyl-8-oxa-2-azaspiro[4.5]decan-2-yl)-1-(4-fluorophenyl)butan-1-one | BRN 1081731 | 333.40 |
| C22H28BrNO | 1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;hydrobromide | 1239-04-9 | 402.40 |
| C22H27NO | 1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | PHENAZOCINE | 321.50 |
| C20H30N2O2 | (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6-oxa-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4,7-dien-17-ol | Furazabol | 330.50 |
| C21H30O3 | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate | Dehydroepiandrosterone acetate | 330.50 |
| C22H28N2O | 3-methyl-2-(2-morpholinoethyl)-2-(1-naphthyl)pentanenitrile | 1241-65-2 | 336.50 |
| C20H29N3O2 | 4-morpholino-2-(2-morpholinoethyl)-2-phenyl-butanenitrile | BUTYRONITRILE, 4-MORPHOLINO-2-(2-MORPHOLINOETHYL)-2-PHENYL- | 343.50 |
| C20H27O4P | 2-ethylhexyl diphenyl phosphate | 2-Ethylhexyl diphenyl phosphate | 362.40 |
| C22H32O3 | [(5S,9S,14S,17S)-2,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | [(5S,9S,14S,17S)-2,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | 344.50 |
| C20H24Cl3N3O | 7-chloro-1-[2-(dimethylamino)-1-methyl-ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one;dihydrochloride | 1242-71-3 | 428.80 |
| C20H22ClN3O | 7-chloro-1-[2-(dimethylamino)-1-methyl-ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 7-chloro-1-[2-(dimethylamino)-1-methyl-ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 355.90 |
| C20H29ClN2O4 | 2-[(2-hydroxy-4-oxo-chromene-3-carbonyl)amino]ethyl-diisobutyl-ammonium chloride | 2-[(2-hydroxy-4-oxo-chromene-3-carbonyl)amino]ethyl-diisobutyl-ammonium chloride | 396.90 |
| C20H28N2O4 | N-[2-(diisobutylamino)ethyl]-2-hydroxy-4-oxo-chromene-3-carboxamide | N-[2-(diisobutylamino)ethyl]-2-hydroxy-4-oxo-chromene-3-carboxamide | 360.40 |
| C23H30O4 | 3-[(10R,13R,14S)-14-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1247-04-7 | 370.50 |
| C22H28O5 | (17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | (17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | 372.50 |
| C22H22N2O3 | 5-cyclohexyl-1,3-diphenyl-hexahydropyrimidine-2,4,6-trione | BARBITURIC ACID, 5-CYCLOHEXYL-1,3-DIPHENYL- | 362.40 |
| C20H13N2NaO4S | sodium 2-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulfonate | sodium 2-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulfonate | 400.40 |
| C22H28Cl3N3O | 7-chloro-1-[3-(diethylamino)propyl]-5-phenyl-3H-1,4-benzodiazepin-2-one;dihydrochloride | 1248-22-2 | 456.80 |
| C22H26ClN3O | 7-chloro-1-[3-(diethylamino)propyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 7-chloro-1-[3-(diethylamino)propyl]-5-phenyl-3H-1,4-benzodiazepin-2-one | 383.90 |
| C25H46Cl2N2O | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;dihydrochloride | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;dihydrochloride | 461.50 |
| C25H44N2O | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | (3S,9S,14S,17S)-17-[3-(dimethylamino)propyl-methyl-amino]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 388.60 |
| C22H29N3O3 | N-[2-[4-[2-(3,4-dimethoxyphenyl)ethyl]piperazin-1-yl]phenyl]acetamide | BRN 0630051 | 383.50 |
| C27H46O2 | (5S)-15-(1,5-dimethylhexyl)-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol | (5S)-15-(1,5-dimethylhexyl)-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol | 402.70 |
| C24H34O5 | [(3S,5R,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] formate | 1250-96-0 | 402.50 |
| C24H31N3O2 | 4-morpholino-2-(2-morpholinoethyl)-2-(1-naphthyl)butanenitrile | alpha,alpha-Bis(2-morpholinoethyl)-1-naphthaleneacetonitrile | 393.50 |
| C27H21FO | 1-benzyloxy-4-[2-(2-fluorophenyl)-1-phenyl-vinyl]benzene | 1-benzyloxy-4-[2-(2-fluorophenyl)-1-phenyl-vinyl]benzene | 380.50 |